Dublin, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/qh...injectable ) has announced the addition of the "Self-injectable Specialty Drugs to 2022" report to their offering. Increases in life expectancy are expected to result in a growing number of patients diagnosed with chronic conditions. To counteract the financial and logistical implications of this trend, pressure from public health and managed care organizations will place a premium on therapeutic self-administration Specialty Injectable formulation and packaging decisions are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. What You Will Learn - What are the currently marketed specialty injectable drugs intended for patient self administration? - What are the therapeutic demand drivers for self-injectable specialty drugs and what are their growth prospects? - What are the key formulation and packaging factors and market development issues for self-administered specialty injectables? - What does the current self-injectable specialty drug market look like, who are the market leaders, and what will this market look like in 2022? - What are the important therapeutic market segments for self-injectable specialty drugs, how large are they, and how fast are they growing? - How important are pharma-device alliances and design partnerships in this market segment? - What is the impact of economic, technology, and regulatory factors in this market? Key Topics Covered: 1. Self-Injectable Specialty Drug Market Dynamics - Injectable Drug Demand Drivers - Drug Development Factors - Market Factors - Technology Factors - Self-Injection Product Design Factors - Ease-of-Use - Safety and Simplicity - Patient Interface - Competitive Landscape - Risks and Opportunities 2. Self-injectable Delivery Device Selection Criteria - Single vs Multi-Dose Devices - Fixed vs Variable Dosing - Lyophilized Drugs/Reconstitution - Disposable vs Reusable Devices - Human Engineering/Ergonomics - Branding/Private Labeling 3. Self-injectable Specialty Drugs - Device Categories - Autoinjectors - Needle-free Injectors - Pen Injectors - Prefilled Syringes - Wearable Injection Devices - Specialty Devices 4. Self-injectable Specialty Drugs - Product Analysis, Therapeutic - Segment Assessments & Forecasts - Anaphylaxis - Anticoagulants - Antivirals - Autoimmune Diseases - Blood Factors - Emergency Medicine - Hematopoietics - Hereditary Diseases - Hormone Replacement - Infectious Disease - Metabolic Diseases - Glycemic Control - Osteoporosis - Neurology - Oncology - Hormones - Immune Modulators - Reproductive Health - Vaccines 5. Company Profiles For more information visit http://www.researchandmarkets.com/research/qh...injectable
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infusions and Injectables
